摘要
背景:虽然已知视网膜色素上皮(RPE)细胞分泌VEGF-A和VEGFR 2,但VEGF自分泌信号的功能尚不清楚。同时,抗血管内皮生长因子(VEGF)治疗也已被广泛应用于眼部血管疾病的治疗.目的:探讨血管内皮生长因子(VEGF)信号传导通路在RPE细胞中的作用及其阻断的作用。方法:用siRNAs对Arpe-19细胞和人原发性RPE细胞进行瞬时转染,敲除VEGF和Hippo信号通路相关基因,通过腺病毒转导介导VEGFR 2的过度表达。采用实时PCR和westernblot方法检测YAP上皮间充质转换(EMT)标记和下游基因的表达。免疫荧光染色法检测组织和小鼠组织中基因的表达。结果:VEGFR 2基因敲除后,在体外和体内均发生上皮间充质转化。VEGFR 2的过表达抑制了转化生长因子β介导的视网膜色素上皮细胞移植。VEGF-C的丢失而不是VEGF-A的丢失导致EMT的发生.机械地说,VEGFR 2消融诱导的RPE细胞EMT是通过激活Hippo通路的效应物YAP而介导的。VEGFR 2和YAP在人增生性玻璃体视网膜病变(PVR)膜中的免疫组化分析显示VEGFR 2阳性细胞与YAP阳性细胞呈负相关。结论:VEGFR 2和VEGF-2在RPE细胞EMT和Hippo通路中具有新的作用。结果表明,VEGFR 2和VEGF-C对维持RPE细胞的正常生理状态具有重要意义。
关键词: 视网膜色素上皮细胞,上皮间充质转换,Hippo通路,YES相关蛋白,血管内皮生长因子,VEGFR 2,眼睛。
Current Molecular Medicine
Title:VEGFR2 and VEGF-C Suppresses the Epithelial-Mesenchymal Transition Via YAP in Retinal Pigment Epithelial Cells
Volume: 18 Issue: 5
关键词: 视网膜色素上皮细胞,上皮间充质转换,Hippo通路,YES相关蛋白,血管内皮生长因子,VEGFR 2,眼睛。
摘要: Background: Whereas retinal pigment epithelial (RPE) cells are known to secrete VEGF-A and VEGFR2, the functions of the autocrine VEGF signaling remain unclear. Meanwhile, anti-VEGF therapies have been applied routinely to treat ocular vascular diseases.
Objective: The aim of this study was to determine the functions of the VEGF signaling in RPE cells and evaluate the consequences of its interruption.
Methods: The genes involved in the VEGF and Hippo signal pathways were knocked down with siRNAs in both ARPE-19 cell line and human primary RPE cells via transient transfection whereas overexpression of VEGFR2 was mediated via adenovirus transduction. Expression of the epithelial-mesenchymal transition (EMT) markers and the downstream genes of YAP were determined by real-time PCR and Western Blot analysis. Immunofluorescence staining was utilized to determine gene expression in tissue and mouse samples.
Results: Knockdown of VEGFR2 results in epithelial-mesenchymal transition in vitro and in vivo. Overexpression of VEGFR2 suppresses TGF β-mediated EMT in RPE cells. Loss of VEGF-C rather than VEGF-A induces EMT. Mechanistically, the VEGFR2 ablation-induced EMT in RPE cells is mediated by activation of YAP, an effector of the Hippo pathway. Finally, the immunohistochemical analysis of VEGFR2 and YAP in human proliferative vitreoretinopathy (PVR) membranes indicates a tendency of an inverse correlation between VEGFR2-positive and YAP-positive cells.
Conclusions: Our results disclose unexpected novel roles of VEGFR2 and VEGF-C in the process of EMT of RPE cells and in the Hippo pathway. The data shown here demonstrated that VEGFR2 and VEGF-C are important to maintain the normal physiological state of RPE cells.
Export Options
About this article
Cite this article as:
VEGFR2 and VEGF-C Suppresses the Epithelial-Mesenchymal Transition Via YAP in Retinal Pigment Epithelial Cells, Current Molecular Medicine 2018; 18 (5) . https://dx.doi.org/10.2174/1566524018666181004115304
DOI https://dx.doi.org/10.2174/1566524018666181004115304 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From the Design to the Clinical Application of Thromboxane Modulators
Current Pharmaceutical Design Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?
Current Pharmaceutical Design Family History and Preclinical Atherosclerosis
Current Hypertension Reviews Can Diabetes Heal?- From Observations to Perspectives
Current Diabetes Reviews Neuroprotective Effects of Ginkgolide B Against Ischemic Stroke: A Review of Current Literature
Current Topics in Medicinal Chemistry JAK2 as a Molecular Marker in Myeloproliferative Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease
Current Neuropharmacology Lipid Rafts and Redox Regulation of Cellular Signaling in Cholesterol Induced Atherosclerosis
Current Cardiology Reviews Inflammation in Peripheral Arterial Disease (PAD)
Current Pharmaceutical Design Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Current Stem Cell Research & Therapy Fenofibrate, Homocysteine and Renal Function
Current Vascular Pharmacology Rheumatoid Arthritis: An Autoimmune Disease with Female Preponderance and Cardiovascular Risk Equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Renovascular Hypertension: Novel Insights
Current Hypertension Reviews Potential Impact of Genetic Variants in Nrf2 Regulated Antioxidant Genes and Risk Prediction of Diabetes and Associated Cardiac Complications
Current Medicinal Chemistry Plasminogen Activator Inhibitor-1 in Vascular Thrombosis
Current Drug Targets Preterm Birth and the Risk of Neurodevelopmental Disorders - Is There a Role for Epigenetic Dysregulation?
Current Genomics Antiplatelet Therapies: Platelet GPIIb / IIIa Antagonists and Beyond
Current Pharmaceutical Design Neurotrophins' Modulation by Olive Polyphenols
Current Medicinal Chemistry Can Exercise Minimize Postprandial Oxidative Stress in Patients with Type 2 Diabetes?
Current Diabetes Reviews